Hospital.Help

Lyon – After evaluating cancer registry data, an international research group sees evidence of overdiagnosis of prostate cancer in Europe. “The current high incidence of prostate cancer in many countries may be inflated by unregulated and opportunistic PSA tests,” writes a team led by Salvatore Vaccarella from the International Agency for Research on Cancer (IARC) in Lyon, France, in the British Medical Journal (BMJ;…